(株)中京医薬品の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証STD | 医薬品 | 4558/E03289 | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2024/03/08 | 日証協 | 529,600株 | -2.13% | 7,300株 | -79.08% | 1,067,079株 | -0.53% | 15,300株 | -6.14% |
| 2024/03/01 | 日証協 | 541,100株 | -0.61% | 34,900株 | 0% | 1,072,779株 | +0.31% | 16,301株 | +150.78% |
| 2024/02/22 | 日証協 | 544,400株 | -0.38% | 0株 | -100% | 1,069,479株 | +0.45% | 6,500株 | -84.18% |
| 2024/02/16 | 日証協 | 546,500株 | +1.84% | 66,200株 | -6.76% | 1,064,679株 | +0.98% | 41,100株 | -29.5% |
| 2024/02/09 | 日証協 | 536,600株 | +11.95% | 71,000株 | 0% | 1,054,379株 | +2.86% | 58,300株 | +555.06% |
| 2024/02/02 | 日証協 | 479,300株 | -0.37% | 0株 | 0% | 1,025,080株 | +0.37% | 8,900株 | -19.1% |
| 2024/01/26 | 日証協 | 481,100株 | 0% | 0株 | -100% | 1,021,279株 | +0.75% | 11,001株 | +3.78% |
| 2024/01/19 | 日証協 | 481,100株 | -0.27% | 1,600株 | 0% | 1,013,679株 | +0.62% | 10,600株 | +34.18% |
| 2024/01/12 | 日証協 | 482,400株 | -0.04% | 0株 | -100% | 1,007,479株 | +0.43% | 7,900株 | -48.37% |
| 2024/01/05 | 日証協 | 482,600株 | -0.12% | 7,000株 | -77.64% | 1,003,180株 | +0.49% | 15,300株 | -75.61% |
| 2023/12/29 | 日証協 | 483,200株 | -1.15% | 31,300株 | +198.1% | 998,271株 | +0.04% | 62,731株 | +13.23% |
| 2023/12/22 | 日証協 | 488,800株 | -3.07% | 10,500株 | +9999.99% | 997,859株 | -0.21% | 55,400株 | +477.08% |
| 2023/12/15 | 日証協 | 504,300株 | -0.02% | 100株 | -99.73% | 999,959株 | +0.26% | 9,600株 | -67.89% |
| 2023/12/08 | 日証協 | 504,400株 | +4.82% | 37,200株 | 0% | 997,410株 | +2.26% | 29,900株 | +35.91% |
| 2023/12/01 | 日証協 | 481,200株 | -1.76% | 0株 | -100% | 975,410株 | -0.7% | 22,000株 | -60.64% |
| 2023/11/24 | 日証協 | 489,800株 | +1.83% | 14,200株 | +4633.33% | 982,310株 | +0.55% | 55,901株 | +146.25% |
| 2023/11/17 | 日証協 | 481,000株 | -0.04% | 300株 | 0% | 976,909株 | +0.48% | 22,701株 | +254.65% |
| 2023/11/10 | 日証協 | 481,200株 | -0.25% | 0株 | -100% | 972,208株 | -0.18% | 6,401株 | +48.86% |
| 2023/11/02 | 日証協 | 482,400株 | +1.56% | 7,600株 | +1420% | 974,007株 | -0.42% | 4,300株 | -44.16% |
※株式分割は考慮していませんのでご注意ください。
Page Top